| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/09/2009 | US20090093541 Melanin eliminator preparation |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093419 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/09/2009 | US20090093418 Novel aminoglycosides and uses thereof in the treatment of genetic disorders |
| 04/09/2009 | US20090093413 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093412 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093409 Neuroprotective synergy of erythropoietin and insulin-like growth factors |
| 04/09/2009 | US20090093407 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/09/2009 | US20090093399 Glycopegylation methods and proteins/peptides produced by the methods |
| 04/09/2009 | US20090092963 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 04/09/2009 | US20090092684 Small molecule antagonists of bcl-2 family proteins |
| 04/09/2009 | US20090092660 Methods and compositions for needleless delivery of particles |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092582 Compositions and methods for modifying properties of biologically active polypeptides |
| 04/09/2009 | US20090092568 Deodorizing composition and method of forming thereof |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | DE102007046861A1 Use of Hypericum perforatum, Conium maculatum and/or Arnica montana in combination for the preparation of a medicament to treat spinal transverse section syndrome, preferably partial or complete paraplegia |
| 04/09/2009 | CA2701618A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701397A1 Nerve cell death inhibitor |
| 04/09/2009 | CA2701155A1 Therapeutic agents for graft-versus-host disease comprising interleukin 6 receptor inhibitor as active ingredient |
| 04/09/2009 | CA2701009A1 Electricity-generating particulates and the use thereof |
| 04/08/2009 | EP2045253A1 a-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
| 04/08/2009 | EP2045244A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2045241A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044957A1 Treatment agent for inflammatory bowel disease |
| 04/08/2009 | EP2044956A1 Hematopoietic stem cell proliferation promoter |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2044939A1 Therapeutic agent for liver fibrosis |
| 04/08/2009 | EP2044928A1 Use of at least one extract of at least one plant of the Ericaceae family in compositions intended for treating signs of skin ageing |
| 04/08/2009 | EP2043665A2 Composition for the enterosorption and management of toxins comprising a calcium aluminosilcilate clay |
| 04/08/2009 | EP2043656A2 New medical use of triazine derivatives |
| 04/08/2009 | EP2043641A2 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 04/08/2009 | EP2043632A2 New indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043631A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1551830B1 Heterocyclically substituted indolinones and their use as receptor tyrosine kinase inhibators |
| 04/08/2009 | EP1545710B1 Use of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide in the treatment of cancer |
| 04/08/2009 | EP1519749B1 Chemotactic factor inhibitor for inhibiting inflammatory reactions |
| 04/08/2009 | EP1461340B1 Trioxane derivatives as antimalaria or anticancer compounds |
| 04/08/2009 | EP1461015B1 Compositions containing both sedative and non-sedative antihistamines |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1430023B1 Substituied urea retinoid agonists ii |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | EP1059925B1 Ep2-receptor agonists as neuroprotective agents for the eye |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | EP0931063B3 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 04/08/2009 | EP0719152B2 Novel therapeutic and dietetic uses of a brain phospholipid-based complex |
| 04/08/2009 | CN101404998A Oral agent for promoting synthesis of tissue collagen |
| 04/08/2009 | CN101404988A Breast cancer treatment regimen |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402630A Preparation of losartan |
| 04/08/2009 | CN101401933A Uses of FGFR2IIIc cell lateral segment in preparing medicament for preventing and treating spontaneous pulmonary fibrosis |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475844C Corticotropin releasing factor receptor 2 agonists |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475838C 10 peptide with cell protection function |
| 04/08/2009 | CN100475836C Mesenchymal stem cell affinity peptide screening and use |
| 04/08/2009 | CN100475833C Process for extracting N6-(2-ethoxyl) adenosine from Paecilomyces Cicadae Samson culture |
| 04/08/2009 | CN100475819C Pseudopolymorphic forms of a HIV protease inhibitor |
| 04/08/2009 | CN100475777C Amide type carboxamide derivative |
| 04/08/2009 | CN100475272C Stabiliser for radiopharmaceuticals |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475254C Anti-fatigue resistibility capsules for improving body immunity and method for making same |
| 04/08/2009 | CN100475207C 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 04/08/2009 | CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/08/2009 | CN100475204C Pilocarpine nitrate dispersible tablet and preparation method thereof |
| 04/08/2009 | CN100475050C Qi-replenishing , hematinic and face beautifying rose syrup tea ,drink and preparation method thereof |
| 04/08/2009 | CN100475046C Method for preparing digestion-promoting spleen-invigorating milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514471 2S)-3-(4-{2-[(Cyclohexylmethyl)(heptyl)amino]-2-oxoethoxy}phenyl)-2-ethoxypropanoic acid; treating lipid disorders (dyslipidemias), insulin resistance |
| 04/07/2009 | US7514469 Cyclooxygenase inhibitors; osteoarthritis, rheumatoid arthritis, and other injuries that result from overuse |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514455 Derivatives of 2-pyridinol or its tautomer 2-pyridone; microorganism comprising Penicillium sp. FO-125 FERM BP-8048; antifungal antibiotics |
| 04/07/2009 | US7514453 Method for enhancing mutant protein activity |
| 04/07/2009 | US7514452 3-(4-hexylphenyl)-2-furancarboxylic acid 2-(4-hydroxy-3-nitrobenzoyl)hydrazide; nonpeptidergic glucagon receptor antagonist; orally; decrease blood sugar levels; hypoglycemic agent; dabetes mellitus type I and II, obesity, hyperlipidemia, gastrointestinal disorders |
| 04/07/2009 | US7514449 inhibitor of activated blood coagulation factor X; N-(5-chloropyridin-2-yl)-3- {[(trans-4-pyrrolidin-1 -ylcyclohexyl)carbonyl]aznino}furo[3,2-c]pyridine-2-carboxaxnide; disorders caused by thrombi and emboli in a mammal; decreased toxicity, and causes few side effects |
| 04/07/2009 | US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 04/07/2009 | US7514429 Benzoxazinone-derived compounds, their preparation and use as medicaments |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening |
| 04/07/2009 | US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | CA2493633C Kinase inhibitors |
| 04/07/2009 | CA2490152C Oxazole derivatives and their use as insulin sensitizers |
| 04/07/2009 | CA2463294C Inhibitors of human phosphatidyl-inositol 3-kinase delta |